Evolus Inc (EOLS)
13.04
+0.41
(+3.25%)
USD |
NASDAQ |
Nov 21, 16:00
13.05
+0.01
(+0.08%)
After-Hours: 20:00
Evolus Enterprise Value: 861.89M for Nov. 21, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 21, 2024 | 861.89M |
| November 20, 2024 | 835.92M |
| November 19, 2024 | 820.73M |
| November 18, 2024 | 795.40M |
| November 15, 2024 | 803.00M |
| November 14, 2024 | 788.43M |
| November 13, 2024 | 811.86M |
| November 12, 2024 | 823.89M |
| November 11, 2024 | 866.95M |
| November 08, 2024 | 902.41M |
| November 07, 2024 | 941.04M |
| November 06, 2024 | 1.101B |
| November 05, 2024 | 1.080B |
| November 04, 2024 | 1.076B |
| November 01, 2024 | 1.097B |
| October 31, 2024 | 1.068B |
| October 30, 2024 | 1.096B |
| October 29, 2024 | 1.092B |
| October 28, 2024 | 1.065B |
| October 25, 2024 | 1.077B |
| October 24, 2024 | 1.035B |
| October 23, 2024 | 1.025B |
| October 22, 2024 | 1.051B |
| October 21, 2024 | 1.063B |
| October 18, 2024 | 1.087B |
| Date | Value |
|---|---|
| October 17, 2024 | 1.088B |
| October 16, 2024 | 1.140B |
| October 15, 2024 | 1.092B |
| October 14, 2024 | 1.127B |
| October 11, 2024 | 1.105B |
| October 10, 2024 | 1.083B |
| October 09, 2024 | 1.097B |
| October 08, 2024 | 1.080B |
| October 07, 2024 | 1.079B |
| October 04, 2024 | 1.070B |
| October 03, 2024 | 1.115B |
| October 02, 2024 | 1.120B |
| October 01, 2024 | 1.113B |
| September 30, 2024 | 1.061B |
| September 27, 2024 | 1.034B |
| September 26, 2024 | 1.059B |
| September 25, 2024 | 1.041B |
| September 24, 2024 | 1.022B |
| September 23, 2024 | 1.007B |
| September 20, 2024 | 1.071B |
| September 19, 2024 | 1.065B |
| September 18, 2024 | 1.051B |
| September 17, 2024 | 1.093B |
| September 16, 2024 | 1.085B |
| September 13, 2024 | 1.131B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
80.71M
Minimum
Mar 16 2020
1.140B
Maximum
Oct 16 2024
495.55M
Average
500.26M
Median
Aug 10 2021
Enterprise Value Benchmarks
| Insulet Corp | 18.87B |
| Perspective Therapeutics Inc | -63.40M |
| Electromed Inc | 223.55M |
| Xtant Medical Holdings Inc | 85.83M |
| Myomo Inc | 138.56M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -19.17M |
| Revenue (Quarterly) | 61.08M |
| Total Expenses (Quarterly) | 74.13M |
| EPS Diluted (Quarterly) | -0.30 |
| Gross Profit Margin (Quarterly) | 70.17% |
| Profit Margin (Quarterly) | -31.38% |
| Earnings Yield | -6.90% |
| Normalized Earnings Yield | -6.902 |